2051 RINGWOOD AVENUE, SAN JOSE, CA
Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition
Financial Results, Press Release
Termination of Tax Receivable Agreement with InCube Labs, LLC
Material disclosure
Rani Therapeutics Enters $42.6M Securities Purchase Agreement
Reports Second Quarter 2025 Financial Results; Provides Corporate Update
News, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Information Statement
Preliminary Information Statement
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload